NewGLAB Pharma CO.,LTD manufactures and sells of CCTV video security solutions in South Korea and internationally. The company offers network cameras, analog cameras, NVRs, and DVRs under the HDPRO name. It also distributes smartphones and earbuds; exports CCTV products; produces dramas and films; manufactures cosmetic cases; and provides management services.In addition, the company engages in the development of pharmaceutical products, including KAT, a metabolism anti-cancer agent targeted for the ATP synthesis inhibition, currently under Phase 1 stage; Taletrectinib (AB-106), an anticancer drug targeted for the ROS1/NTRK, currently under Phase 2 stage; and a COVID-19 treatment targeted for the TMPRSS2 inhibition, currently under Phase 1 stage. Further, it is involved in the development, manufacture, and sale of temperature-sensitive products, such as cold chain packaging solutions, refrigerators and freezers, temperature management devices, logistics-related mechanical equipment, and cold storage equipment, as well as provision of bio-logistics services. The company was formerly known as NewGLAB CO.,LTD and changed its name to NewGLAB Pharma CO.,LTD. NewGLAB Pharma CO.,LTD was founded in 2004 and is headquartered in Bucheon-si, South Korea.